Get access to our best features
Get access to our best features
Published 3 months ago

Gilead Sciences Shows Resilience with Flat Revenue and Increased Profit Margin in Full Year 2023 Results

Summary by claytoncountyregister.com
Gilead Sciences, a leading biotechnology company, has reported its full year 2023 financial results, indicating a flat revenue of US$27.1b compared to the previous year. Despite this, the company experienced a significant increase in net income, reaching US$5.67b, reflecting a 23% growth from the previous year. The company’s profit margin also demonstrated improvement, rising from 17% in FY 2022 to 21% in FY 2023. This positive shift contributed…

0 Articles

All
Left
Center
Right
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe
Ground News Article Assistant
Not enough coverage to generate an Article Assistant.

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)